Skip to main content

Closed

KLRS: Kalaris Therapeutics Inc Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-46.7%

Financially safe

Stretched

Debt / equity0.02×

Interest coverage0.0×

Current ratio12.14×

Kalaris Therapeutics Inc

KLRSNASDAQ Global Market·USD·Closed

Kalaris Therapeutics Inc

KLRSNASDAQ·USD·Closed

$3.51

+0.86%

$3.51

+$0.03 (0.86%)

52W Range

14thpctl

Volume

0.26×avg

Mkt Cap

65.65MUSD

P/E

-1.6TTM

Div Yield

–ann

52W Range

14thpctl

Volume

0.26×avg

Market Cap

65.65MUSD

P/E Ratio

-1.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings